- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 121794, 7 pages
Participation of Chloride Channels in the Anxiolytic-Like Effects of a Fatty Acid Mixture
1Laboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, 91190 Xalapa, VER, Mexico
2Unidad Periférica Xalapa, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 91190 Xalapa, VER, Mexico
Received 4 April 2013; Accepted 20 August 2013
Academic Editor: Brynn Levy
Copyright © 2013 Juan Francisco Rodríguez-Landa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. Bormann, “The “ABC” of GABA receptors,” Trends in Pharmacological Sciences, vol. 21, no. 1, pp. 16–19, 2000.
- S. J. Enna, “The GABA receptors,” in ,The GABA Receptors, S. J. Enna and H. Möhler, Eds., pp. 1–22, Humana Press, Totowa, NJ, USA, 2007.
- D. Bitran, M. Shiekh, and M. McLeod, “Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain receptors,” Journal of Neuroendocrinology, vol. 7, no. 3, pp. 171–177, 1995.
- A. Fernandez-Guasti and O. Picazo, “Flumazenil blocks the anxiolytic action of allopregnanolone,” European Journal of Pharmacology, vol. 281, no. 1, pp. 113–115, 1995.
- M. Farrant and R. A. Webster, “GABA antagonists, their use and mechanisms of action,” in Drugs as Tools in Neurotransmitter Research. Neuromethods, A. A. Boulton, G. B. Baker, and A. V. Juorio, Eds., vol. 12, pp. 161–219, Humana Press, Clifton, NJ, USA, 1989.
- M. Chebib and G. A. R. Johnston, “The “ABC” of GABA receptors: a brief review,” Clinical and Experimental Pharmacology and Physiology, vol. 26, no. 11, pp. 937–940, 1999.
- D. S. Reddy and S. K. Kulkarni, “Role of and mitochondrial diazepam binding inhibitor receptors in the anti stress activity of neurosteroids in mice,” Psychopharmacology, vol. 128, no. 3, pp. 280–292, 1996.
- C. Lopez-Rubalcava, A. Saldivar, and A. Fernandez-Guasti, “Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics,” Pharmacology Biochemistry and Behavior, vol. 43, no. 2, pp. 433–440, 1992.
- S. K. Kulkarni and K. Sharma, “Alprazolam modifies animal behaviour on elevated plus-maze,” Indian Journal of Experimental Biology, vol. 31, no. 11, pp. 908–911, 1993.
- D. Treit, J. P. J. Pinel, and H. C. Fibiger, “The inhibitory effect of diazepam on conditioned defensive burying is reversed by picrotoxin,” Pharmacology Biochemistry and Behavior, vol. 17, no. 2, pp. 359–361, 1982.
- D. Bitran, R. J. Hilvers, and C. K. Kellog, “Anxiolytic effects of 3a-hydroxy-5a[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the receptor,” Brain Research, vol. 561, no. 1, pp. 157–161, 1991.
- G. A. R. Johnston, “ antagonists,” Seminars in Neuroscience, vol. 3, no. 3, pp. 205–210, 1991.
- C. M. Contreras, J. F. Rodríguez-Landa, A. G. Gutiérrez-García, M. R. Mendoza-López, R. I. García-Ríos, and J. Cueto-Escobedo, “Anxiolytic-like effects of human amniotic fluid and its fatty acids in Wistar rats,” Behavioural Pharmacology, vol. 22, pp. 655–662, 2011.
- C. M. Contreras, A. G. Gutiérrez-García, R. Mendoza-López, J. F. Rodríguez-Landa, B. Bernal-Morales, and C. Díaz-Marte, “Amniotic fluid elicits appetitive responses in human newborns: fatty acids and appetitive responses,” Developmental Psychobiology, vol. 55, no. 3, pp. 221–231, 2013.
- M. Samochocki and J. Strosznajder, “Modulatory action of arachidonic acid on /chloride channel receptor function in adult and aged brain cortex membranes,” Neurochemistry International, vol. 23, no. 3, pp. 261–267, 1993.
- D. Treit, “Animal models for the study of anti-anxiety agents: a review,” Neuroscience and Biobehavioral Reviews, vol. 9, no. 2, pp. 203–222, 1985.
- G. Griebel, D. J. Sanger, and G. Perrault, “The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands,” Psychopharmacology, vol. 124, no. 3, pp. 245–254, 1996.
- National Research Council, Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC, USA, 1985.
- J. P. J. Pinel and D. Treit, “Burying as a defensive response in rats,” Journal of Comparative and Physiological Psychology, vol. 92, no. 4, pp. 708–712, 1978.
- A. A. Walf and C. A. Frye, “The use of the elevated plus maze as an assay of anxiety-related behavior in rodents,” Nature Protocols, vol. 2, no. 2, pp. 322–328, 2007.
- K. Hirani, A. N. Sharma, N. S. Jain, R. R. Ugale, and C. T. Chopde, “Evaluation of GABAergic neuroactive steroid 3α-hydroxy-5α- pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats,” Psychopharmacology, vol. 180, no. 2, pp. 267–278, 2005.
- T.-C. Hwang, S. E. Guggino, and W. B. Guggino, “Direct modulation of secretory chloride channels by arachidonic and other cis unsaturated fatty acids,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 15, pp. 5706–5709, 1990.
- M. Nielsen, M.-R. Witt, and H. Thøgersen, “[3H]Diazepam specific binding to rat cortex in vitro is enhanced by oleic, arachidonic and docosahexenoic acid isolated from pig brain,” European Journal of Pharmacology, vol. 146, no. 2-3, pp. 349–353, 1988.
- R. W. Ordway, J. J. Singer, and J. V. Walsh Jr., “Direct regulation of ion channels by fatty acids,” Trends in Neurosciences, vol. 14, no. 3, pp. 96–100, 1991.
- A. Leaf, Y.-F. Xiao, and J. X. Kang, “Interactions of n-3 fatty acids with ion channels in excitable tissues,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 67, no. 2-3, pp. 113–120, 2002.
- M. D. Majewska, N. L. Harrison, R. D. Schwartz, J. L. Barker, and S. M. Paul, “Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor,” Science, vol. 232, no. 4753, pp. 1004–1007, 1986.
- K. W. Gee, M. B. Bolger, R. E. Brinton, H. Coirini, and B. S. McEwen, “Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action,” Journal of Pharmacology and Experimental Therapeutics, vol. 246, no. 2, pp. 803–812, 1988.
- M. D. Majewska, “Neurosteroids: endogenous bimodal modulators of the receptor. Mechanism of action and physiological significance,” Progress in Neurobiology, vol. 38, no. 4, pp. 379–395, 1992.
- N. L. Harrison and M. A. Simmonds, “Modulation of the GABA receptor complex by a steroid anaesthetic,” Brain Research, vol. 323, no. 2, pp. 287–292, 1984.
- M. D. Majewska, J.-C. Bisserbe, and R. L. Eskay, “Glucocorticoids are modulators of receptors in brain,” Brain Research, vol. 339, no. 1, pp. 178–182, 1985.
- A. M. Hosie, M. E. Wilkins, H. M. A. Da Silva, and T. G. Smart, “Endogenous neurosteroids regulate receptors through two discrete transmembrane sites,” Nature, vol. 444, no. 7118, pp. 486–489, 2006.
- I. Ferando and I. Mody, “ receptor modulation by neurosteroids in models of temporal lobe epilepsies,” Epilepsia, vol. 9, pp. 89–101, 2012.
- N. L. Harrison, M. D. Majewska, J. W. Harrington, and J. L. Barker, “Structure-activity relationships for steroid interaction with the γ-aminobutyric acid(A) receptor complex,” Journal of Pharmacology and Experimental Therapeutics, vol. 241, no. 1, pp. 346–353, 1987.
- T. G. Kokate, B. E. Svensson, and M. A. Rogawski, “Anticonvulsant activity of neurosteroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation,” Journal of Pharmacology and Experimental Therapeutics, vol. 270, no. 3, pp. 1223–1229, 1994.
- M. Herrera-Ruiz, A. González-Carranza, A. Zamilpa, E. Jiménez-Ferrer, M. Huerta-Reyes, and V. M. Navarro-García, “The standardized extract of Loeselia mexicana possesses anxiolytic activity through the γ-amino butyric acid mechanism,” Journal of Ethnopharmacology, vol. 138, no. 2, pp. 261–267, 2011.
- I. Morganstern, Z. Ye, S. Liang, S. Fagan, and S. F. Leibowitz, “Involvement of cholinergic mechanisms in the behavioral effects of dietary fat consumption,” Brain Research, vol. 1470, pp. 24–34, 2012.